Coronavirus vaccine update: AstraZeneca resumes clinical trials in Japan, US still paused
Coronavirus vaccine: Several global trials of the vaccine, AZD1222, were put on hold last month after an unexplained illness in a study participant. While most trials have resumed, US trials are still on pause FDA widens safety probe into Astrazeneca's COVID-19 vaccine
AstraZeneca's large, late-stage U.S. trial has remained on hold since Sept. 6, after a study participant in Britain fell ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (LODR) Regulations, 2015, the Company is intimating the request received relating to Loss of share certificate and issue of duplicate share certificate as per attached details.
Does Centre have Rs 80,000 crore for COVID-19 vaccine, asks Serum Institute's Adar Poonawalla
SII has partnered with five global pharma companies including AstraZeneca to produce 1 billion doses of its vaccine candidate half of which it has pledged to India. US health secretary says AstraZeneca trial in United States remains on hold: Report
Alex Azar said that the FDA's investigation, which has continued even after the trial has resumed outside of the United States, shows that the agency takes safety of the vaccine seriously. 3 Covid vaccine-makers reveal blueprints'
AstraZeneca has become the third company to reveal the blueprint of its Covid-19 vaccine candidate that is presently undergoing late-stage clinical t ASTRAZENECA PHARMA INDIA LTD. - 506820 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to the Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we hereby inform you that a one-on-one meeting is scheduled to be held with analysts/investment managers, as per the details attached. AstraZeneca denies vaccine trial subject had nerve ailment
A diagnosis soon after vaccination raises the chances that the vizrus used in the vaccine or some other component somehow triggered the rare reaction USFDA's Hahn plans significant work with AstraZeneca in Covid trial inquiry
The top US Food and Drug Administration official confirmed AstraZeneca's US Covid-19 vaccine trial is on hold AstraZeneca coronavirus vaccine trial in US on hold until midweek: Report
AstraZeneca on Saturday said it had restarted its trial in Britain after regulators completed their review of a serious side effect in one trial participant there